Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Department of Health and Human Services
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |